Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor

Raj, 2009, Role of interleukin-6 in the anemia of chronic disease, Semin Arthritis Rheum, 35, 382, 10.1016/j.semarthrit.2008.01.006 Xing, 1998, IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses, J Clin Invest, 101, 311, 10.1172/JCI1368 Lyons, 2001, Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6, Infect Immun, 69, 2589, 10.1128/IAI.69.4.2589-2595.2001 Taga, 2005, Role of IL-6 in the neural stem cell differentiation, Clin Rev Allergy Immunol, 28, 249, 10.1385/CRIAI:28:3:249 van de Loo, 1997, Interleukin-6 reduces cartilage destruction during experimental arthritis – a study in interleukin-6-deficient mice, Am J Pathol, 151, 177 Peltola, 2002, Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels, Seizure, 11, 44, 10.1053/seiz.2001.0575 Algan, 1996, Role of tumor necrosis factor alpha in particulate-induced bone resorption, J Orthop Res, 14, 30, 10.1002/jor.1100140107 Seck, 2002, Expression of interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women, Bone, 30, 217, 10.1016/S8756-3282(01)00652-4 Kayamori, 2010, Roles of Interleukin-6 and Parathyroid Hormone-Related Peptide in osteoclast formation associated with oral cancers significance of Interleukin-6 synthesized by stromal cells in response to cancer cells, Am J Pathol, 176, 968, 10.2353/ajpath.2010.090299 Hierl, 1998, Regulation of interleukin-6 expression in human osteoblastic cells in vitro, Exp Clin Endocrinol Diabetes, 106, 324, 10.1055/s-0029-1211993 Seki, 2007, Capsaicin induces the production of IL-6 in human upper respiratory epithelial cells, Life Sci, 80, 1592, 10.1016/j.lfs.2007.01.037 Tsai, 2004, Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels, Oral Dis, 10, 360, 10.1111/j.1601-0825.2004.01041.x Yoshida, 2005, Methotrexate suppresses inflammatory agonist induced interleukin 6 synthesis in osteoblasts, J Rheumatol, 32, 787 Dai, 2006, TNF alpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics, Bone, 38, 509, 10.1016/j.bone.2005.10.007 Patil, 2004, p38 MAPK regulates IL-1 beta induced IL-6 expression through mRNA stability in osteoblasts, Immunol Invest, 33, 213, 10.1081/IMM-120034231 Knuepfer, 2005, Role of angiotensin II and corticotropin-releasing hormone in hemodynamic responses to cocaine and stress, Regul Pept, 127, 1, 10.1016/j.regpep.2004.12.010 Horiuchi, 1999, Signaling mechanism of the AT2 Angiotensin II receptor: crosstalk between AT1 and AT2 receptors in cell growth, Trends Endocrinol Metab, 10, 391, 10.1016/S1043-2760(99)00191-5 Ji, 2009, PPARα activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway, Biochem Pharmacol, 78, 1186, 10.1016/j.bcp.2009.06.095 Weng, 2000, Ethanol alters angiotensin II stimulated mitogen activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence, Eur J Pharmacol, 398, 323, 10.1016/S0014-2999(00)00313-7 Kranzhöfer, 1999, Angiotensin induces inflammatory activation of human vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 19, 1623, 10.1161/01.ATV.19.7.1623 Tsuchiya, 2006, Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes, Am J Physiol Metab, 291, E771 Proudfoot, 2003, Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1, J Pharmacol Exp Ther, 305, 846, 10.1124/jpet.102.047795 Nishiya, 2001, Effects of various antihypertensive drugs on the function of osteoblast, Biol Pharm Bull, 24, 628, 10.1248/bpb.24.628 Gulcan, 2008, Are there any effects of angiotensin II receptor blockers on postmenopausal osteoporosis?, Med Hypotheses, 70, 701, 10.1016/j.mehy.2007.07.011 Shimizu, 2008, Angiotensin II accelerates osteoporosis by activating osteoclasts, FASEB J, 22, 2465, 10.1096/fj.07-098954 Altun, 2004, Association between activated renin angiotensin system and bone formation in hemodialysis patients: is the bone mass genetically determined by ACE gene polymorphism?, Ren Fail, 26, 425, 10.1081/JDI-120039830 Wiens, 2006, Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies, J Intern Med, 24, 581 Rejnmark, 2006, Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study, J Hypertens, 24, 581, 10.1097/01.hjh.0000203845.26690.cb Haneda, 1999, Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade, Eur J Pharmacol, 365, 1, 10.1016/S0014-2999(98)00857-7 Nawaz, 2006, Copper-induced stimulation of extracellular signal-regulated kinase in trout hepatocytes: the role of reactive oxygen species, Ca2+, and cell energetics and the impact of extracellular signal-regulated kinase signaling on apoptosis and necrosis, Toxicol Sci, 92, 464, 10.1093/toxsci/kfl006 Suzuki, 2000, Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells, J Bone Miner Res, 15, 95, 10.1359/jbmr.2000.15.1.95 Chen, 2005, Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens, J Biol Chem, 280, 4632, 10.1074/jbc.M411530200 Koizumi, 2003, Cell density and growth-dependent down-regulation of both intracellular calcium responses to agonist stimuli and expression of smooth-surfaced endoplasmic reticulum in MC3T3-E1 osteoblast-like cells, J Biol Chem, 278, 6433, 10.1074/jbc.M210243200 Kofla, 2007, Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression, J Microbiol Methods, 68, 178, 10.1016/j.mimet.2006.07.011 Tomizawa, 2009, Induction of gene expression in response to globular adiponectin in vascular endothelial cells, Life Sci, 85, 457, 10.1016/j.lfs.2009.07.012 Hu, 2002, Downstream effectors of oncogenic ras in multiple myeloma cells, Blood, 101, 3126, 10.1182/blood-2002-08-2640 Mundy, 2007, Osteoporosis and inflammation, Nutr Rev, 65, S147, 10.1301/nr.2007.dec.S147-S151 Harjacek, 2000, Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis, J Rheumatol, 27, 497 Kawana, 2003, Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice, J Electron Microsc, 52, 515, 10.1093/jmicro/52.6.515 Takaoka, 1999, Interleukin-1 beta induces interleukin-6 production through the production of prostaglandin E-2 in human osteoblasts, MG-63 cells, J Biochem, 126, 553, 10.1093/oxfordjournals.jbchem.a022485 Tsutamoto, 2000, Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure, J Am Coll Cardiol, 35, 714, 10.1016/S0735-1097(99)00594-X Ishida, 1998, Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells, Circ Res, 82, 7, 10.1161/01.RES.82.1.7 Papparella, 2005, Angiotensin II-induced over-activation of p47phox in fibroblasts friorn hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II?, J Hypertens, 23, 793, 10.1097/01.hjh.0000163148.97459.9d Kondo, 2004, Activation of osteoblastic functions by a mediator of pain, bradykinin, Biochem Pharmacol, 68, 1423, 10.1016/j.bcp.2004.06.007 Holownia, 2007, The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells, Naunyn Schmiedebergs Arch Pharmacol, 6, 157, 10.1007/s00210-007-0192-4